Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2015 Oct 14;8(11):1272–1281. doi: 10.1016/j.jcmg.2015.06.016

Figure 3. Traditional coronary CTA assessment and ACS in the ROMICAT II trial.

Figure 3

Flow diagram depicts the risk stratification based on the conventional troponin followed by the traditional assessment of coronary CTA for the presence of coronary atherosclerotic plaque and ≥50% stenosis.